Risk definition and management strategies in retinoblastoma: current perspectives
Fariba Ghassemi, Alireza Khodabande Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Tehran Province, Islamic Republic of Iran Abstract: This manuscript focuses on high-risk factors of metastatic disease in ...
Ghassemi F, Khodabande A
doaj
Background: This case report aims to describe an adverse reaction following intra-arterial melphalan chemotherapy in a 48-year-old female patient with choroidal melanoma.
Arthur Sampaio Zupelli +6 more
doaj +1 more source
The Evolving Role of Intra-arterial Chemotherapy in Adult and Pediatric Cancers: A Comprehensive Review. [PDF]
Tangella AV.
europepmc +1 more source
Atypical Event Profiling of Intra-Arterial Chemotherapy. [PDF]
Bach A, Villegas VM, Gold AS, Murray TG.
europepmc +1 more source
Incidence and Risk Factors for Neutropenia After Intra-Arterial Chemotherapy for Retinoblastoma.
Lee DH +4 more
europepmc +1 more source
Association of Lower Age and Cardiorespiratory Events during Intra-Arterial Chemotherapy for Retinoblastoma: A Prospective Observational Study. [PDF]
Lima MF +6 more
europepmc +1 more source
Effectiveness of Intra-Arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma: Relevance of a Multidisciplinary Setting. [PDF]
Castela G +9 more
europepmc +1 more source
Global research trends on intra-arterial chemotherapy for retinoblastoma: A bibliometric and visualized study. [PDF]
Visconti-Lopez FJ, Saal-Zapata G.
europepmc +1 more source
Ocular survival after intra-arterial chemotherapy for retinoblastoma improves with accrual of experience and programmatic evolution. [PDF]
Marasligiller SA +7 more
europepmc +1 more source
In Reply to: "Response to intra-arterial chemotherapy in patients with adenoid cystic carcinoma of lacrimal gland". [PDF]
Costa PA, Tse DT, Benedetto P.
europepmc +1 more source

